Tag archief: English Only

Boehringer Ingelheim Begins Clinical Development of First-In-Class Treatment for Fibrotic Diseases

INGELHEIM, Germany & SINGAPORE–(BUSINESS WIRE)– Boehringer Ingelheim announced today that it has launched clinical development of its first-in-class IL-11 inhibitor antibody BI 765423 with a...

ADVA publishes record revenues in Q1 2023

Quarterly revenues up 5.2% year-over-year to EUR 179.4 million Pro forma EBIT increased strongly to EUR 9.7 million (5.4% of revenues) Outlook for fiscal year...

IFF Reports First Quarter 2023 Results

NEW YORK–(BUSINESS WIRE)– IFF (NYSE: IFF) reported financial results for the first quarter ended March 31, 2023. Management Commentary “We delivered first quarter 2023 results...

Hytera Prevails Over Patent Lawsuit Filed by Motorola Solutions

The Düsseldorf Court of Appeals found the patent-in-suit not infringed by Hytera and HMF and fully dismissed Motorola Solutions’ complaint. SHENZHEN, China–(BUSINESS WIRE)– Hytera Communications...

Adtran brings energy-efficient multigigabit broadband to homes and businesses with next-gen ONTs

News summary: Demand for high-capacity Ethernet connectivity is soaring, driven by remote work, gamers and cloud-based applications Versatile, high-performance SDX 630 Series XGS-PON ONTs offer...

Board to officially launch its new innovation programme at Board Beyond

Board LABS offers customers and partners the opportunity to collaborate on new technologies for advanced planning, forecasting, and optimization LONDON–(BUSINESS WIRE)– Board International, a leading...

Paceline Equity Partners Joins United Nations-Supported Principles for Responsible Investment

DALLAS–(BUSINESS WIRE)– Paceline Equity Partners, LLC (“Paceline”), a Dallas-based private equity manager, today announced that it has become a signatory of the UN-supported Principles for...

SES: Q1 2023 Results

LUXEMBOURG–(BUSINESS WIRE)– SES S.A. announces financial results for the three months ended 31 March 2023. Solid Q1 2023 performance and on track to deliver Full...

Vertex Announces U.S. FDA Approval for KALYDECO® (ivacaftor) to Treat Eligible Infants With CF Ages 1 Month and Older

-First and only CFTR modulator approved for this age group- BOSTON–(BUSINESS WIRE)– Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration...

IFF Declares Dividend for Second Quarter 2023

NEW YORK–(BUSINESS WIRE)– IFF (NYSE: IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.81 per share of its...

Rimini Street Announces Fiscal First Quarter 2023 Financial and Operating Results

Financial Highlights Include: Quarterly revenue of $105.5 million, up 7.8% year over year Gross margin of 62.7% compared to prior year of 62.0% Net income...

Regnology Acquires Metadata Technology

Latest acquisition enhances Regnology’s technology offering for regulators with SDMX solutions for central banks and statistical agencies LONDON & FRANKFURT, Germany–(BUSINESS WIRE)– Regnology, a leading...

Profen to Deliver High Performance Networks across Türkiye and beyond with SES’s O3b mPOWER system

Telecommunications, government agencies, humanitarian aid organisations and energy companies will have access to unrivalled satellite connectivity for mobile backhaul, disaster recovery, private 5G and more...

Hedosophia European Growth- Initiation of Redemption and Liquidation

  AMSTERDAM–(BUSINESS WIRE)– Hedosophia European Growth (the “Company“) today announces that it will not conclude a Business Combination ahead of its Business Combination Deadline of...

SPEVIGO® granted Breakthrough Therapy Designation in the U.S. for the prevention of generalized pustular psoriasis flares

Based on results from the EFFISAYIL™ 2 trial, which met its primary and key secondary endpoints for the prevention of generalized pustular psoriasis (GPP) flares1,2,3...